Screener
Cue Biopharma CUE Q1 2025 Annual earnings
Reported May 12, 2025 · Before market open
Revenue$421.0KMiss by $846.7K
EPS-$0.17Miss by $0.03
Revenue estimate$1.3M
EPS estimate-$0.14
Next report
Nov 11, 2026 (In 1 week)Revenue estimate$1.0M
EPS estimate-$2.24
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Cue Biopharma report Q1 2025 earnings?
- Cue Biopharma (CUE) reported Q1 2025 earnings on May 12, 2025 before market open.
- What were Cue Biopharma's Q1 2025 revenue and EPS?
- Cue Biopharma reported revenue of $421.0K and eps of $-0.17 for Q1 2025.
- Did Cue Biopharma beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $1.3M by $846.7K. EPS missed the consensus estimate of $-0.14 by $0.03.
- How did Cue Biopharma's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 75.5% from $1.7M a year earlier and eps grew 32.0% from $-0.25.
- Where can I find Cue Biopharma's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-069124) and the 10-K periodic report (0000950170-25-047677) directly on SEC EDGAR. The filing index links above go to sec.gov.
